Skip to main content
Premium Trial:

Request an Annual Quote

Microbix to Develop Virus Vectors for GE Healthcare Cell Analysis Platforms

NEW YORK, July 26 (GenomeWeb News) - Microbix Biosystems will develop a portfolio of recombinant adenoviruses for use with GE Healthcare's sub-cellular imaging instruments, the company said today.


Under the terms of the agreement, Microbix will develop the vectors for the IN Cell Analyzer 3000 and 1000, which GE Healthcare added to its portfolio following its April acquisition of Amersham. According to an official statement, "a range of ready-to-use assays will be developed to enable researchers to study key cellular events in real time and in a cell line of choice."


Financial terms of the agreement were not disclosed.


The Scan

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.